COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 167 filers reported holding COHERUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6 | 0.0% | 3,609 | +39.9% | 0.00% | – |
| Q1 2024 | $6 | -86.7% | 2,580 | -80.8% | 0.00% | – |
| Q4 2023 | $45 | +9.8% | 13,424 | +23.3% | 0.00% | – |
| Q3 2023 | $41 | -69.2% | 10,887 | -65.1% | 0.00% | -100.0% |
| Q2 2023 | $133 | -36.4% | 31,198 | +1.9% | 0.00% | -50.0% |
| Q1 2023 | $209 | -19.6% | 30,618 | -6.6% | 0.00% | 0.0% |
| Q4 2022 | $260 | -99.9% | 32,799 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $315,000 | +34.0% | 32,799 | +1.2% | 0.00% | +50.0% |
| Q2 2022 | $235,000 | -41.8% | 32,413 | +3.6% | 0.00% | -33.3% |
| Q1 2022 | $404,000 | -61.9% | 31,287 | -52.9% | 0.00% | -25.0% |
| Q4 2021 | $1,060,000 | +93.4% | 66,436 | +94.9% | 0.00% | -20.0% |
| Q3 2021 | $548,000 | +13.9% | 34,094 | -1.9% | 0.01% | +25.0% |
| Q2 2021 | $481,000 | +186.3% | 34,760 | +234.9% | 0.00% | 0.0% |
| Q1 2020 | $168,000 | -13.8% | 10,380 | -4.0% | 0.00% | 0.0% |
| Q4 2019 | $195,000 | -11.4% | 10,812 | +8.7% | 0.00% | -20.0% |
| Q2 2019 | $220,000 | – | 9,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,100,000 | $1,903,000 | 1.75% |
| AlphaCentric Advisors LLC | 1,000,000 | $1,730,000 | 1.27% |
| Tejara Capital Ltd | 1,030,386 | $1,782,568 | 0.65% |
| Rubric Capital Management LP | 10,400,000 | $17,992,000 | 0.47% |
| Birchview Capital, LP | 270,000 | $467,100 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,050,000 | $1,816,500 | 0.18% |
| Bridge City Capital, LLC | 316,009 | $546,696 | 0.18% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $5,252,413 | 0.16% |
| Tyche Wealth Partners LLC | 215,902 | $373,510 | 0.09% |
| Pennant Investors, LP | 168,100 | $290,813 | 0.08% |